講者：王孟廷 教授
論文投稿後可能會收到期刊審稿人意見，無論是正面或負面意見，最終期刊主編決定接受論文與否都會根據你如何回覆這些評審意見來決定。然而，如何有禮貌地回覆或反駁審稿人意見，甚至是上訴主編的拒絕發表決定即為一門大學問。本次課程講師將分享自身投稿經驗，讓學員了解如何回覆審稿人意見，藉以提升論文接受率。
講者介紹：
王孟廷教授為美國亞歷桑納大學藥事經濟暨效果評估學博士，目前為國防醫學院藥學系教授。王教授為國際知名的藥物流行病學與藥物經濟學家，透過分析全民健康保險研究資料庫，探討藥物療效、安全性及經濟性評估與藥物潛在新適應症相關議題，相關著作曾刊登於美國醫學會內科學雜誌、美國醫學會精神科雜誌。
現職：
特殊事蹟&獎項
2020 Best Reviewer Award for Journal of Food and Drug Analysis
2019 Dr. Robert Kho-Seng Lin Excellent Research Awardees (highest research award in the center), granted by National Defense Medical Center, Taipei, Taiwan
2019 Best Reviewer Award for Journal of Food and Drug Analysis
2018 Dr. Robert Kho-Seng Lin Excellent Research Awardees (highest research award in the center), granted by National Defense Medical Center, Taipei, Taiwan
2018 Outstanding Alumni Awardees, awarded by Pharmacy Alumni Association, National Defense Medical Center, Taipei, Taiwan
2018 Best Reviewer Award for Pharmacoepidemiology and Drug Safety
摘選著作:
Wang MT, Lin CW, Tsai CL, Wang YH, Lai JH, Yeh CB, Huang YL, Hsu YJ*. Use of antipsychotics and the risk of acute respiratory failure among adults: A disease risk score-matched nested case-control study. [published online ahead of print April 26, 2020]. British Journal of Clinical Pharmacology. doi:10.1111/bcp.14321. (SCI; IF=3.74; 26.3% in Pharmacology & Pharmacy)
Lai JH, Wang MT, Wu CC, Huang YL, Lu CH, Liou JT*. Risk of severe hypoglycemic events from amiodarone-sulfonylureas interactions: A population-based nested case-control study [published online ahead of print June 1, 2020]. Pharmacoepidemiology and Drug Safety. doi:10.1002/pds.5034 (Co-first author; SCI; IF=2.92; 28.0% in Pharmacology & Pharmacy)
Wang MT*, Lai JH, Tsai CL, Liou JT. Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease. Journal of Food and Drug Analysis. 2019; 27: 657-670 (review article; SCI; IF=4.73; 9.4% in Pharmacology & Pharmacy)
Liou JT, Lin CW, Tsai CL, Wang YH, Lai JH, Hsu YJ, Wang MT*. Risk of severe cardiovascular events from add-on tiotropium in chronic obstructive pulmonary disease. Mayo Clinic Proceedings (SCI; IF=6.94; 7.9% in Medicine, General & Internal). 2018; 93(10): 1462-1473.
Wang MT*, Liou JT, Lin CW, Tsai CL, Wang YH, Hsu YJ, Lai JH. Association of cardiovascular risk with inhaled long-acting bronchodilators in patients with chronic obstructive pulmonary disease: A nested case-control study. JAMA Internal Medicine. 2018; 178(2): 229-238. (SCI; IF=18.65; 4.2% in Medicine, General & Internal)
Wang MT*, Wang YH, Tsai CL, Dual bronchodilators and β-blockade for cardiovascular Risk in chronic obstructive pulmonary disease—Reply. JAMA Internal Medicine. 2018;178(5):731. doi:10.1001/jamainternmed.2018.1450 (SCI; IF=18.65; 4.2% in Medicine, General & Internal)
